Cargando…
Failure of topical DNCB immunotherapy in most patients with non-clinical carcinoma of the cervix.
Autores principales: | Guthrie, D., Way, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009939/ https://www.ncbi.nlm.nih.gov/pubmed/444400 |
Ejemplares similares
-
Topical Spilanthol Inhibits MAPK Signaling and Ameliorates Allergic Inflammation in DNCB-Induced Atopic Dermatitis in Mice
por: Huang, Wen-Chung, et al.
Publicado: (2019) -
Nano-titanium dioxide modulates the dermal sensitization potency of DNCB
por: Hussain, Salik, et al.
Publicado: (2012) -
The topical application of low-temperature argon plasma enhances the anti-inflammatory effect of Jaun-ointment on DNCB-induced NC/Nga mice
por: Choi, Jeong-Hae, et al.
Publicado: (2017) -
Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice
por: Wang, Yanjie, et al.
Publicado: (2022) -
Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice
por: Kim, Young-Je, et al.
Publicado: (2018)